Group 1 - The core stock price of Ruimait rose by 2.02% to 84.97 CNY per share, with a total market capitalization of 7.613 billion CNY as of January 23 [1] - The company experienced a net inflow of main funds amounting to 4.8854 million CNY, with large orders accounting for 20.08% of total purchases [1] - Year-to-date, Ruimait's stock price has decreased by 0.86%, with a 5-day decline of 5.84% and a 20-day increase of 2.99% [2] Group 2 - Ruimait, established on July 27, 2001, specializes in the research, production, and sales of medical devices and consumables in the respiratory health sector, focusing on conditions like obstructive sleep apnea syndrome (OSA) and chronic obstructive pulmonary disease (COPD) [2] - The company's revenue composition includes 64.19% from home respiratory therapy products, 32.67% from consumables, 3.05% from medical products, and 0.10% from other sources [2] - As of September 30, 2025, Ruimait reported a revenue of 808 million CNY, reflecting a year-on-year growth of 34.24%, and a net profit of 180 million CNY, with a growth of 43.87% [3] Group 3 - Ruimait has distributed a total of 228 million CNY in dividends since its A-share listing [4] - As of September 30, 2025, the number of shareholders increased by 16.36% to 7,971, while the average circulating shares per person decreased by 14.20% to 7,080 shares [3] - Among the top ten circulating shareholders, Huatai-PineBridge Healthcare Mixed Fund is the sixth largest, holding 1.2953 million shares as a new shareholder [4]

Core Viewpoint - Recently, Ruimait announced an expected net profit attributable to shareholders for the fiscal year 2025 to be between 190 million to 235 million yuan, representing an increase of 22.28% to 51.24% compared to the same period last year [1] Financial Performance - The net profit after deducting non-recurring gains and losses for 2025 is projected to be between 129 million to 164 million yuan, reflecting a year-on-year increase of 38.97% to 77.37% [1] - The primary driver for this growth is attributed to an increase in operating revenue [1] Market Conditions - The impact of inventory destocking in the overseas U.S. market has dissipated [1] - Revenue in the North American region has significantly increased compared to the previous year [1]

Core Viewpoint - The company, 瑞迈特 (301367.SZ), expects a significant increase in net profit for 2025, driven by revenue growth and recovery in the North American market [1] Financial Projections - The projected net profit attributable to shareholders for 2025 is between 190 million and 235 million yuan, representing a year-on-year increase of 22.28% to 51.24% [1] - The net profit after excluding non-recurring gains and losses is expected to be between 128.5 million and 164 million yuan, indicating a year-on-year growth of 38.97% to 77.37% [1] - The anticipated operating revenue for 2025 is between 1.08 billion and 1.2 billion yuan [1] Market Factors - The growth in net profit is primarily attributed to an increase in operating revenue, as the impact of inventory destocking in the U.S. market has subsided [1] - There has been a significant revenue increase in the North American region compared to the previous year [1]

Group 1 - The core viewpoint is that Ruimai Technology (301367) has not yet applied artificial intelligence technology in its product development and marketing, resulting in no sales related to AI [1] - The company will continue to monitor industry technological developments and will timely apply cutting-edge technologies that meet development needs for product innovation and business expansion [1] - The company aims to continuously enhance its core competitiveness and will fulfill information disclosure obligations in case of significant progress [1]

Group 1 - The core viewpoint of the article is that Ruimait (301367) has forecasted a significant increase in net profit for 2025, estimating it to be between 190 million to 235 million yuan, which represents a year-on-year growth of 22.28% to 51.24% [2] - The growth in net profit is primarily attributed to an increase in operating revenue, as the impact of inventory destocking in the U.S. market has subsided, leading to a substantial revenue increase in the North American region compared to the previous year [2]

Core Viewpoint - The company, 瑞迈特 (301367.SZ), forecasts a significant increase in net profit for the fiscal year 2025, indicating strong growth potential in its financial performance [1] Financial Performance - The company expects net profit attributable to shareholders to be between 190 million to 235 million yuan, representing a year-on-year growth of 22.28% to 51.24% [1] - The net profit after deducting non-recurring gains and losses is projected to be between 129 million to 164 million yuan, with a year-on-year increase of 38.97% to 77.37% [1] Revenue Growth - The announcement highlights an increase in the company's operating revenue, with the impact of inventory destocking in the U.S. market having dissipated [1] - Revenue from the North American region has significantly increased compared to the previous year [1]

Core Viewpoint - The company, Ruimai Te (瑞迈特), forecasts a significant increase in net profit and revenue for the year 2025, indicating strong growth potential in the upcoming period [1] Financial Performance - The expected net profit for 2025 is projected to be between 190 million to 235 million yuan, representing a year-on-year growth of 22.28% to 51.24% [1] - The anticipated operating revenue for 2025 is estimated to be between 1.08 billion to 1.2 billion yuan, compared to 843 million yuan in the previous year [1] Market Dynamics - The impact of inventory destocking in the overseas U.S. market is expected to have dissipated by 2025, leading to a substantial revenue increase in the North American region compared to the previous year [1]

Core Viewpoint - The company expects a significant increase in net profit for the fiscal year 2025, driven by revenue growth and recovery in the North American market [1] Financial Performance - The projected net profit attributable to shareholders is estimated to be between 190 million to 235 million yuan, representing a year-on-year growth of 22.28% to 51.24% [1] - The net profit after excluding non-recurring gains and losses is expected to be between 128 million to 164 million yuan, reflecting a year-on-year increase of 38.97% to 77.37% [1] - Anticipated operating revenue is forecasted to be between 1.08 billion to 1.2 billion yuan, compared to 843 million yuan in the same period last year [1] Market Dynamics - The growth in performance is primarily attributed to an increase in operating revenue, with the impact of inventory destocking in the U.S. market having subsided [1] - Revenue from the North American region has seen a significant increase compared to the previous year [1]

Financial Projections - The company expects a net profit of between 190 million and 235 million CNY for 2025, representing a year-on-year increase of 22.28% to 51.24%[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 128.5 million and 164 million CNY, reflecting a growth of 38.97% to 77.37% compared to the previous year[5] - The expected operating revenue for 2025 is between 1.08 billion and 1.2 billion CNY, up from 843.48 million CNY in the previous year[5] Market Recovery - The significant increase in revenue is attributed to the recovery of the North American market, with the impact of inventory destocking in the U.S. having dissipated[7] Audit and Evaluation - The financial data presented is based on preliminary estimates by the company's finance department and has not yet been audited by an external accounting firm[6] - The final performance data will be subject to professional evaluation and audit, with specific figures to be disclosed in the company's 2025 annual report[8] - The company has communicated with the auditing firm regarding the performance forecast, and there are no significant discrepancies between the two parties[6] Investor Advisory - The company advises investors to make cautious decisions and be aware of investment risks due to the preliminary nature of the performance forecast[8] Performance Forecast Period - The performance forecast period is from January 1, 2025, to December 31, 2025[3] Announcement Date - The board of directors announced the performance forecast on January 19, 2026[10]

具体来看，合计持有公司4.999%股份的股东能金有限公司及其一致行动人广州市金垣创业投资合伙企 业（有限合伙）计划在自减持计划公告之日起15个交易日后的3个月内以集中竞价方式或大宗交易方式 减持公司股份累计不超过220.8万股，占公司总股本比例2.49%（总股本已剔除公司回购专用账户中的股 份数量）。 此外，合计持有公司15.88%股份的股东珠海合晅投资中心（有限合伙）及其一致行动人上海盛旻创业 投资合伙企业（有限合伙）计划在自减持计划公告之日起15个交易日后的3个月内以集中竞价方式或大 宗交易方式减持本公司股份累计不超过220.8万股，占公司总股本比例2.49%。 （文章来源：北京商报） 北京商报讯1月16日晚间，瑞迈特（301367）发布公告称，多名股东拟合计减持不超过4.98%公司股 份。 ...